FDA Warns Drugmakers Over Missing Clinical Trial Results
The FDA sent letters to 2,200+ companies in 2026 warning of fines for failing to submit clinical trial results to ClinicalTrials.gov.
3 articles tagged "Fda Regulation"
The FDA sent letters to 2,200+ companies in 2026 warning of fines for failing to submit clinical trial results to ClinicalTrials.gov.
The FDA is requesting expanded statutory authority over direct-to-consumer drug ads in its FY2027 budget, targeting misleading pharmaceutical promotions.
A four-month FDA meeting cancellation proved fatal for Kezar Life Sciences, highlighting how regulatory delays can devastate small biotech companies.